Ariosa Diagnostics, Inc v. Sequenom, Inc., No. 14-1139 (Fed. Cir. June 12, 2015)

From the Opinion

The passage below is extracted verbatim from the opening of the document. It has not been editorially summarized — consult the full opinion for the court's complete reasoning.

This appeal is from a grant of summary judgment of invalidity of the asserted claims of U.S. Patent No. 6,258,540 (“the ’540 patent”). The United States District Court for the Northern District of California found that the asserted claims of the ’540 patent are not directed to patent eligible subject matter and are therefore invalid under 35 U.S.C. § 101. For the reasons explained below, we affirm. ARIOSA DIAGNOSTICS, INC v. SEQUENOM, INC. 3 I In 1996, Drs.